Thursday, December 19, 2024
HomeTagsFYCOMPA

FYCOMPA

Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA

Catalyst Pharmaceuticals, Inc. ("Catalyst"), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, announced that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics